On the recordJuly 15, 2003
what my local pharmacist said today was we would have not that great of a drug crisis in the United States if we had Canadian pricing or German pricing or other EU pricing. The three reasons that Mr. Trewhitt gave my local newspapers as to why this reimportation is a failed strategy, there is no guarantee any savings would be passed on to consumers. The Lipitor, save 43 percent. My belief is that if you have reimportation, my pharmacist in Holland, Michigan, or my pharmacist in Ludington, Michigan, if he can access these drugs through a purchasing agreement with a reputable pharmaceutical house in Canada, do I think he is going to buy or stay in business if he is paying $288 for it and the pharmacy down the street can get it for $165? I am sorry, he is going to be buying it, and the consumers will see the savings. The consumers in Canada obviously are seeing the savings. The savings have moved down. It is uncertain whether the safety of reimported drugs can be assured. Give me a break. You told me how many pounds or tons of bananas we import and these types of things. The technology exists where we can put the controls in place that we can maintain the integrity. But the bottom line is reimportation will not happen. What will happen is that we will see an equalization of the prices between the Canadian and the U.S. markets and the European markets and the U.S. and the U.S. seniors and the U.S. government.
Source
govinfo.gov




